Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 21, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
An expert cardiologist, sleep specialist, and pulmonologist, share insights on the awareness and treatment of sleep disorders, including insomnia, that co-occur with other health conditions in this NeurologyLive® Peer Exchange.
Mind Moments®, a podcast from NeurologyLive®, brings you exclusive interviews with Stephen Krieger, MD; Richard Isaacson, MD; and Jessica Ailani, MD, who discussed their experience at the 4th International Congress on the Future of Neurology, as well as the outlook of the care paradigms of their respective specialties.
In the latest edition of our in-depth Q&A series, the adult neurologist at Allegheny Health Network discussed the ever-changing landscape of therapies for myasthenia gravis and the shift toward more holistic disease management.
Tabby Khan, MD, MPH, spoke with NeurologyLive® about the impact that the COVID-19 has had on patients with Alzheimer disease and how telehealth has helped with providing care for those patients during a pandemic.
A cross-sectional study conducted by Nabil El Ayoubi, MD, et al showed that retinal measurements in patients with “potential” neuromyelitis optica spectrum disorder were similar to those with definite neuromyelitis optica spectrum disorder.